Evidence map›Paper›PMID 35689124›Full record

ArticleEuropean journal of nutrition2022

Recommendation on an updated standardization of serum magnesium reference ranges.

Andrea Rosanoff, Christina West, Ronald J Elin, Oliver Micke, Shadi Baniasadi, Mario Barbagallo, Emily Campbell, Fu-Chou Cheng, Rebecca B Costello, Claudia Gamboa-Gomez and 22 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in European journal of nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05630339 (Efficacy and Security of the Magnesium and Vitamin D Combination as Adjuvant Treatment of Post-COVID Syndrome. A Randomised Double-blind Clinical Trial), which is not on this map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
7.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05630339 nacompletednot on this map

Efficacy and Security of the Magnesium and Vitamin D Combination as Adjuvant Treatment of Post-COVID Syndrome. A Randomised Double-blind Clinical Trial

TypeinterventionalSponsorCoordinación de Investigación en Salud, MexicoRan2022 to 2023Enrolled150ConditionsPost-COVID-19 Syndrome, Long COVID, Vitamin D Deficiency, Magnesium DeficiencyArmsMagnesium chloride, Vitamin D, Inert placebo
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 75 citations in OpenAlex.

  1. Trial
  2. Trial
  3. The dietary calcium-to-magnesium ratio and its association with glycemic control in type 2 diabetes: a cross-sectional study.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Article
  4. Article
  5. Article
  6. Magnesium: Hype and Health Benefits.Current nutrition reports · 2026
    Review
  7. Article
  8. Article
  9. Observational
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 15 countries.

Andrea RosanoffCMER Center for Magnesium Education and Research, 13-1255 Malama Street, Pahoa, HI, 96778, USA. arosanoff@gmail.com.ORCID http://orcid.org/0000-0002-7811-9517
Christina West, White House, TN, USA.
Ronald J ElinDepartment of Pathology and Laboratory Medicine, University of Louisville, Louisville, KY, USA.
Oliver MickeDepartment of Radiotherapy and Radiation Oncology, Franziskus Hospital, Kiskerstraße 26, 33615, Bielefeld, Germany.
Shadi BaniasadiTracheal Diseases Research Centre, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mario BarbagalloGeriatric Unit, Department of Medicine, University of Palermo, Palermo, Italy.
Emily CampbellCMER Center for Magnesium Education and Research, 13-1255 Malama Street, Pahoa, HI, 96778, USA.
Fu-Chou ChengDepartment of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan, People's Republic of China.
Rebecca B CostelloCMER Center for Magnesium Education and Research, 13-1255 Malama Street, Pahoa, HI, 96778, USA.
Claudia Gamboa-GomezBiomedical Research Unit of Mexican Social Security Institute, Durango, Mexico.
Fernando Guerrero-RomeroResearch Group on Diabetes and Chronic Illnesses, Durango, Mexico.
Nana Gletsu-MillerIndiana University School of Public Health, Bloomington, IN, USA.
Bodo von EhrlichInternal Medicine Private Practice, Kempten, Germany.
Stefano IottiDepartment of Pharmacy and Biotechnology (FaBit), National Institute of Biostructures and Biosystems, Università di Bologna, Bologna, Italy.
Ka KaheDepartments of Obstetrics and Gynecology and Epidemiology, Columbia University Irving Medical Center, New York, NY, USA.
Dae Jung KimAjou University Hospital, Suwon-si, Korea.
Klaus KistersSt. Anna Hospital, Medizinische Klinik I, Herne, Germany.
Martin KolisekBiomedical Center in Martin, Jessenius Medical Faculty in Martin, Comenius University, Mala Hora 4D, Martin, 03601, Slovakia.
Anton KrausGerman Society for Magnesium Research E.V, Postfach 1256, 82327, Tutzing, Germany.
Jeanette A MaierDepartment of Biomedical and Clinical Sciences L. Sacco, Università Di Milano, Milan, Italy.
Magdalena Maj-ZurawskaFaculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Warsaw, Poland.
Lucia MerolleTransfusion Medicine Unit, AUSL-IRCCS Di Reggio Emilia, Reggio Emilia, Italy.
Mihai NechiforDepartment of Pharmacology, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.
Guitti PourdowlatChronic Respiratory Diseases Research Centre, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Michael ShechterClinical Research Unit, Leviev Cardiothoracic and Vascular Center, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Yiqing SongDepartment of Epidemiology, Fairbanks School of Public Health, Indiana University Richard M, Indianapolis, IN, USA.
Yee Ping TeohDepartment of Clinical Biochemistry, Wrexham Maelor Hospital, Wales, UK.
Rhian M TouyzResearch Institute of the McGill University Health Centre, Montreal, QC, Canada.
Taylor C WallaceCMER Center for Magnesium Education and Research, 13-1255 Malama Street, Pahoa, HI, 96778, USA.
Kuninobu YokotaJikei University School of Medicine, Tokyo, Japan.
Federica WolfDepartment of Translational Medicine and Surgery, Fondazione Policlinico Gemelli Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Università Cattolica del Sacro Cuore, Rome, Italy.
MaGNet Global Magnesium Project (MaGNet)
Center Point · USMasih Daneshvari Hospital · IRAjou University Hospital · KRAzienda Sanitaria Unità Locale di Reggio Emilia · ITColumbia University Irving Medical Center · USComenius University Bratislava · SKDartmouth College · USGeorge Mason University · USGrigore T. Popa University of Medicine and Pharmacy · ROIndiana University Bloomington · USIndiana University – Purdue University Indianapolis · USJikei University School of Medicine · JPKempten University of Applied Sciences · DEMcGill University Health Centre · CAMexican Social Security Institute · MXSt. Anna Hospital · DESt. Franziskus Hospital · DETaichung Veterans General Hospital · TWTel Aviv University · ILThe White House · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSerum magnesium is the most frequently used laboratory test for evaluating clinical magnesium status. Hypomagnesemia (low magnesium status), which is associated with many chronic diseases, is diagnosed using the serum magnesium reference range. Currently, no international consensus for a magnesemia normal range exists. Two independent groups designated 0.85 mmol/L (2.07 mg/dL; 1.7 mEq/L) as the low cut-off point defining hypomagnesemia. MaGNet discussions revealed differences in serum magnesium reference ranges used by members' hospitals and laboratories, presenting an urgent need for standardization.

methodsWe gathered and compared serum magnesium reference range values from our institutions, hospitals, and colleagues worldwide.

resultsSerum magnesium levels designating "hypomagnesemia" differ widely. Of 43 collected values, only 2 met 0.85 mmol/L as the low cut-off point to define hypomagnesemia. The remainder had lower cut-off values, which may underestimate hypomagnesemia diagnosis in hospital, clinical, and research assessments. Current serum magnesium reference ranges stem from "normal" populations, which unknowingly include persons with chronic latent magnesium deficit (CLMD). Serum magnesium levels of patients with CLMD fall within widely used "normal" ranges, but their magnesium status is too low for long-term health. The lower serum magnesium reference (0.85 mmol/L) proposed specifically prevents the inclusion of patients with CLMD.

conclusionsWidely varying serum magnesium reference ranges render our use of this important medical tool imprecise, minimizing impacts of low magnesium status or hypomagnesemia as a marker of disease risk. To appropriately diagnose, increase awareness of, and manage magnesium status, it is critical to standardize lower reference values for serum magnesium at 0.85 mmol/L (2.07 mg/dL; 1.7 mEq/L).

Indexed as

MagnesiumHumansReference StandardsReference ValuesMagnesiumChronic latent magnesium deficitCLMDHypomagnesemiaSerum magnesiumSerum magnesium reference range

Identifiers

PMID35689124
PMCPMC9186275
OpenAlexW4281668320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.